Status:
COMPLETED
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka Pharmaceutical Co., Ltd.
Conditions:
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Eligibility:
All Genders
12-70 years
Brief Summary
To collect characteristics of patients with ADPKD across a broad population, over time to better understand disease progression (signs, symptoms and outcomes). Association with total kidney volume cha...
Eligibility Criteria
Inclusion
- existing diagnosis of ADPKD by modified-Ravine criteria
- Total kidney volume \>= 300 cc/m height by ultrasound or \>= 250 cc/m height by MRI
Exclusion
- Current or expected (within the next six months) interventions for the treatment of ADPKD affecting kidney volume
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
3409 Patients enrolled
Trial Details
Trial ID
NCT01430494
Start Date
June 1 2011
End Date
October 1 2014
Last Update
April 23 2015
Active Locations (266)
Enter a location and click search to find clinical trials sorted by distance.
1
Otsuka Investigational Site 1
Peoria, Arizona, United States, 85381
2
Otsuka Investigational Site 2
Peoria, Arizona, United States, 85381
3
Otsuka Investigational Site
Tempe, Arizona, United States, 85284
4
Otsuka Investigational Site
Azusa, California, United States, 91702